Innoviva, Inc. (INVA)
NASDAQ: INVA · Real-Time Price · USD
19.43
+0.07 (0.36%)
Nov 5, 2024, 4:00 PM EST - Market closed

Innoviva Revenue

Innoviva had revenue of $99.90M in the quarter ending June 30, 2024, with 23.34% growth. This brings the company's revenue in the last twelve months to $330.50M, up 13.80% year-over-year. In the year 2023, Innoviva had annual revenue of $310.46M, down -6.30%.

Revenue (ttm)
$330.50M
Revenue Growth
+13.80%
P/S Ratio
3.72
Revenue / Employee
$2,950,857
Employees
112
Market Cap
1.22B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023310.46M-20.88M-6.30%
Dec 31, 2022331.34M-60.53M-15.45%
Dec 31, 2021391.87M55.07M16.35%
Dec 31, 2020336.79M75.78M29.03%
Dec 31, 2019261.02M12.00K0.00%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Brookdale Senior Living 2.92B
Indivior 1.18B
Guardian Pharmacy Services 1.12B
U.S. Physical Therapy 621.23M
Alphatec Holdings 572.74M
ANI Pharmaceuticals 538.95M
CareDx 297.08M
Gyre Therapeutics 111.59M
Revenue Rankings